196 related articles for article (PubMed ID: 32727204)
21. A novel biomarker for increased intracranial pressure in idiopathic intracranial hypertension.
Bingöl Kızıltunç P; Atilla H
Jpn J Ophthalmol; 2021 May; 65(3):416-422. PubMed ID: 33420540
[TBL] [Abstract][Full Text] [Related]
22. Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis.
Marzoli SB; Ciasca P; Curone M; Cammarata G; Melzi L; Criscuoli A; Bussone G; D'Amico D
Neurol Sci; 2013 May; 34 Suppl 1():S143-5. PubMed ID: 23695066
[TBL] [Abstract][Full Text] [Related]
23. Vitreous humor diffusion measurements from diffusionweighted imaging in idiopathic intracranial hypertension.
Caglı B; Tuncel SA; Yılmaz E; Tekatas A; Ermıs V
Ideggyogy Sz; 2016 Nov; 69(11-12):405-410. PubMed ID: 29733558
[TBL] [Abstract][Full Text] [Related]
24. Long-term evolution of papilledema in idiopathic intracranial hypertension: observations concerning two cases.
Piovesan EJ; Lange MC; Piovesan Ldo R; de Almeida SM; Kowacs PA; Werneck LC
Arq Neuropsiquiatr; 2002 Jun; 60(2-B):453-7. PubMed ID: 12131949
[TBL] [Abstract][Full Text] [Related]
25. Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica.
Brisby H; Olmarker K; Rosengren L; Cederlund CG; Rydevik B
Spine (Phila Pa 1976); 1999 Apr; 24(8):742-6. PubMed ID: 10222523
[TBL] [Abstract][Full Text] [Related]
26. Idiopathic intracranial hypertension without papilledema.
Marcelis J; Silberstein SD
Arch Neurol; 1991 Apr; 48(4):392-9. PubMed ID: 2012512
[TBL] [Abstract][Full Text] [Related]
27. Effects of lowering cerebrospinal fluid pressure on the shape of the peripapillary retina in intracranial hypertension.
Sibony P; Kupersmith MJ; Honkanen R; Rohlf FJ; Torab-Parhiz A
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8223-31. PubMed ID: 25406288
[TBL] [Abstract][Full Text] [Related]
28. Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension.
Engel S; Halcour J; Ellwardt E; Uphaus T; Steffen F; Zipp F; Bittner S; Luessi F
Fluids Barriers CNS; 2023 Jan; 20(1):3. PubMed ID: 36631830
[TBL] [Abstract][Full Text] [Related]
29. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome.
Cinciripini GS; Donahue S; Borchert MS
Am J Ophthalmol; 1999 Feb; 127(2):178-82. PubMed ID: 10030560
[TBL] [Abstract][Full Text] [Related]
30. The relationship between idiopathic intracranial hypertension and obesity.
Hannerz J; Ericson K
Headache; 2009 Feb; 49(2):178-84. PubMed ID: 19222591
[TBL] [Abstract][Full Text] [Related]
31. Coexistence of idiopathic intracranial hypertension and optic disc drusen in a latin american patient: case report.
Escobar Gómez HD; Jaramillo Velásquez DL; Cárdenas Angelone PL; Martínez Malo LK; Vélez Álvarez C
Arch Soc Esp Oftalmol (Engl Ed); 2021 Jun; 96(6):326-331. PubMed ID: 34092287
[TBL] [Abstract][Full Text] [Related]
32. Association between visual parameters and neuroimaging features of idiopathic intracranial hypertension.
Padhye LV; Van Stavern GP; Sharma A; Viets R; Huecker JB; Gordon MO
J Neurol Sci; 2013 Sep; 332(1-2):80-5. PubMed ID: 23850064
[TBL] [Abstract][Full Text] [Related]
33. Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients.
Kabatas N; Eren Y; Nalcacioglu P; Caliskan S; Bicer T; Comoglu SS; Gurdal C
Int Ophthalmol; 2021 Apr; 41(4):1467-1477. PubMed ID: 33481155
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension.
Eren Y; Kabatas N; Guven H; Comoglu S; Gurdal C
Acta Neurol Belg; 2019 Sep; 119(3):351-357. PubMed ID: 30120685
[TBL] [Abstract][Full Text] [Related]
35. Can optic disc vessel density help in cases of residual disc elevation after shunt surgery in cases of idiopathic intracranial hypertension?
El-Haddad NSEM; Ismael SA; Shabaan N; Ghoraba Y; Elhamrawy EA; Lamie N; Atwaa F; Mohamed SA; Mansour MN
Lasers Med Sci; 2024 May; 39(1):125. PubMed ID: 38713436
[TBL] [Abstract][Full Text] [Related]
36. Idiopathic intracranial hypertension in child.
Zemba M; Dimirache AE; Rogoz RE
Rom J Ophthalmol; 2020; 64(4):423-431. PubMed ID: 33367182
[TBL] [Abstract][Full Text] [Related]
37. Clinical and Magnetic Resonance Imaging Characteristics of Postfenestration Optic Nerve Sheath Pseudomeningoceles.
Rafailov L; Rubinstein D; Wladis EJ; Mirani N; Frohman LP; Langer PD; Turbin RE
Ophthalmic Plast Reconstr Surg; 2019; 35(2):159-164. PubMed ID: 30134388
[TBL] [Abstract][Full Text] [Related]
38. Retinal nerve fiber layer changes and visual field loss in idiopathic intracranial hypertension.
Hedges TR; Legge RH; Peli E; Yardley CJ
Ophthalmology; 1995 Aug; 102(8):1242-7. PubMed ID: 9097754
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension.
Tarrats L; Hernández G; Busquets JM; Portela JC; Serrano LA; González-Sepúlveda L; Sánchez-Pérez JR
Int Forum Allergy Rhinol; 2017 Jun; 7(6):615-623. PubMed ID: 28383199
[TBL] [Abstract][Full Text] [Related]
40. Effect of optic nerve sheath fenestration for idiopathic intracranial hypertension on retinal nerve fiber layer thickness.
Starks V; Gilliland G; Vrcek I; Gilliland C
Orbit; 2016; 35(2):87-90. PubMed ID: 26928128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
